When firms develop new products there are number of different types of products they could be developing. This video teaches you a few of the most important types of new products that firms will ...

There are a number of considerations that can help streamline the pathway to the clinic. One of the first is which vector ...

FDA's new guidance streamlines biosimilar development, reducing costs and regulatory hurdles and potentially enhancing market ...

The NFL has not publicly addressed a study that involved its top medical official and reported the benefits of Guardian Caps ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.The agency issued draft guidance that would simplify the study ...

By emphasizing analytical studies instead of routine clinical trials, the FDA signals its intent to reduce the cost (often estimated at $100 million to $300 million) and time (typically 6–9 years) ...

The agency will no longer require studies comparing copycat biologics to their branded counterparts, which could help ...

The Center for Biosimilars connects professionals with insights on biosimilars, health economics, regulatory outcomes, and ...

Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) ...

Our friends at Ford Authority report that a former GM executive has accepted an executive position with cross-town rival Ford. GM alumnus Salvatore (Sam) Basile is the new Vice President of Advanced ...

Social media could be costing your tween some of their brain power, a new study says. Children between 9 and 13 years of age who spent more time on social media performed worse on tests of reading, ...